Christopher Richard Anzalone, Chief Executive Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 102,850 shares at $15.07 ($1.5M) on 2025-03-13, disclosed to the SEC on 2025-03-17.
Open-market sale of $1.5M ARWR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.07 | 51,425 | $775K | 50.0% |
| 2 | $15.07 | 51,425 | $775K | 50.0% |
| Total | $15.07 avg | 102,850 | $1.5M | 100% |
| Filing → |
| ARWR | SELL | 2025-12-23 | $3.5M | — | Filing → |
| ARWR | SELL | 2025-12-19 | $10.9M | — | Filing → |
| ARWR | SELL | 2025-12-16 | $24.6M | — | Filing → |